Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial
Supplementary Data
Supplementary Data
Supplementary Figure 1
- docx file
Supplementary Table 1
- docx file
Supplementary Table 2
- docx file